For research use only. Not for therapeutic Use.
MCL-1/BCL-2-IN-2 (Cat.No:I017579) is a small molecule inhibitor that targets both MCL-1 and BCL-2 proteins, which play key roles in regulating cell survival and apoptosis. By inhibiting these proteins, MCL-1/BCL-2-IN-2 promotes programmed cell death in cancer cells and shows potential as an anti-cancer therapeutic. Further studies are ongoing to explore its efficacy and safety in preclinical and clinical settings.
Catalog Number | I017579 |
CAS Number | 2163793-44-8 |
Molecular Formula | C₂₀H₁₅BrN₂O₂S |
Purity | ≥95% |
Target | Bcl-2 Family |
Reference | [1]. Wang Z, et al. Proteolysis Targeting Chimeras for the Selective Degradation of Mcl-1/Bcl-2 Derived from Nonselective Target Binding Ligands. J Med Chem. 2019 Sep 12;62(17):8152-8163. |